# OnCo record beat-meso (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/beat-meso/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "beat-meso", "NCT03762018" ;
  schema:name "BEAT-meso (ETOP 13-18)"@en ;
  schema:description "Adding atezolizumab to bevacizumab-chemotherapy slowed progression but did not lengthen survival overall; it did help patients with non-epithelioid tumours."@en ;
  schema:url <https://onco.cc/trials/beat-meso/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03762018>, <https://ascopubs.org/doi/10.1200/JCO.2024.42.17_suppl.LBA8002> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  schema:startDate "2019-04-30" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/pemetrexed/> ;
  onco:companies <https://onco.cc/companies/etop-ibcsg/> ;
  onco:terms <https://onco.cc/terms/epithelioid-vs-sarcomatoid/> .